1. Academic Validation
  2. Gpc3 selectively suppresses subcutaneous adipogenesis in diet-induced obesity

Gpc3 selectively suppresses subcutaneous adipogenesis in diet-induced obesity

  • PLoS Biol. 2026 Mar 4;24(3):e3003700. doi: 10.1371/journal.pbio.3003700.
Yan Li 1 2 Ming Tao 3 Carlos F Ibáñez 1 4 5 6 7 Meng Xie 5 6 8 9
Affiliations

Affiliations

  • 1 Chinese Institute for Brain Research, Zhongguancun Life Science Park, Beijing, China.
  • 2 Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
  • 3 Department of General Surgery, Peking University Third Hospital, Beijing, China.
  • 4 School of Life Sciences, Peking University, Beijing, China.
  • 5 Peking-Tsinghua Center for Life Sciences, Beijing, China.
  • 6 PKU-IDG/McGovern Institute for Brain Research, Beijing, China.
  • 7 Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
  • 8 School of Psychological and Cognitive Sciences, Peking University, Beijing Key Laboratory of Behavior and Mental Health, Beijing, China.
  • 9 Biosciences and Nutrition Unit, Department of Medicine Huddinge, Karolinska Institute, Huddinge, Sweden.
Abstract

Subcutaneous and visceral adipose depots employ distinct expansion strategies in response to dietary cues, yet the molecular regulators underlying these depot-specific adaptations remain poorly understood. Through integrated proteomic profiling of human subcutaneous and visceral adipose tissues from paired obese/non-obese donors and temporal transcriptomic analysis of mouse adipose stem and progenitor cells (ASPCs) during dietary transitions, we identified Glypican 3 (Gpc3) as an obesity-responsive gene exhibiting reciprocal expression patterns between depots. ASPC-specific Gpc3 deletion in mice amplified high-fat diet-induced weight and fat mass gain, with a selective enhancement of expansion in inguinal white adipose tissue (WAT) without affecting epididymal WAT. Mechanistically, Gpc3 loss biased ASPC fate toward adipogenesis over proliferation through depot-specific modulation of canonical Wnt signaling. These findings establish Gpc3 as a regulator for regional adipose plasticity, offering a molecular target for reprogramming pathological fat distribution in obesity and related metabolic disorders.

Figures
Products